LYMPHOMA, HODGKINS

Clinical trials for LYMPHOMA, HODGKINS explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, HODGKINS trials appear

Sign up with your email to follow new studies for LYMPHOMA, HODGKINS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Supercharged donor cells target stubborn blood cancers

Disease control Completed

This study tested a new cell therapy for adults whose B-cell blood cancers (like leukemia or lymphoma) came back or never fully went away after a donor stem cell transplant. Researchers collected immune cells from the original transplant donor, genetically engineered them to bett…

Matched conditions: LYMPHOMA, HODGKINS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

LYMPHOMA, HODGKINS

Get alerted when new LYMPHOMA, HODGKINS trials appear

Supercharged donor cells target stubborn blood cancers